Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer
Clinical trial NCT01823978 · COMPLETED
Trial details
- NCT number
- NCT01823978
- Sponsor
- Bellicum Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-05-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.